Zimmer Biomet with clear technical picture, shares between support and resistance
Published on 06/25/2026 at 18:21 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
By Daniel Hoffmann, Chart & Technicals desk. Reviewed prior to publication on 2026-06-25, 18:21.
Zimmer Biomet (US98956P1021) sits in a defined trading corridor on the NYSE, with the latest close around the low-90-dollar mark according to recent price data. The focus today is on the technical setup with support near 84.56 dollars and resistance around 93.58 dollars in the healthcare equipment segment. TradingKey technical overview
What recent data show
Zimmer Biomet shares, trading under ticker ZBH on the NYSE, most recently changed hands at about 90.57 dollars at the regular close on 2026-06-24, reflecting a daily gain of roughly 3.43 percent and a market capitalization near 17.5 billion dollars. TradingKey price snapshot
A separate dataset from another pricing source shows an early 2026-06-25 quotation of 91.54 dollars for ZBH and a daily increase of 1.09 percent at that time, underlining that the stock remains anchored in the low-90-dollar range and within its established band. FinancialData quote overview
Technical levels and signals
From a chart perspective, Zimmer Biomet currently trades between a resistance level around 93.58 dollars and a support zone near 84.56 dollars, a range that technical analysts describe as suitable for range-bound swing approaches in the healthcare equipment and supplies industry. TradingKey technical overview
Momentum indicators paint a constructive picture: one technical service assigns Zimmer Biomet a price momentum score of 9.38, ranking it 16th out of 204 stocks in its healthcare equipment & supplies peer group, with four current buy signals and one sell signal across key indicators and moving averages. TradingKey indicator summary
Background and price data on Zimmer Biomet
All current quotes, historical data and additional news on the Zimmer Biomet shares can be found in the dedicated topic area and in the company’s own investor information.
How Zimmer Biomet earns its money
Zimmer Biomet generates revenue as a medical device specialist, with a portfolio centered on orthopedic reconstruction, sports medicine, spine, craniomaxillofacial products and related surgical technologies for hospitals and surgeons worldwide, anchored by longstanding operations in Warsaw, Indiana and other key markets. FinancialData company profile
Where the shares trade today
The Zimmer Biomet shares (US98956P1021) most recently traded around 92.36 dollars during market hours on the NYSE on 2026-06-25, implying an equity value of about 18.1 billion dollars at that quotation. TradingKey sentiment snapshot
Key data on the Zimmer Biomet shares
- Company: Zimmer Biomet Holdings, Inc.
- ISIN: US98956P1021
- WKN: A1409B
- Ticker: ZBH
- Trading venue: NYSE
- Price (as of 2026-06-25, 16:00): 92.36 USD
- Market cap: 18.06 billion USD (as of 2026-06-25)
- Sector / industry: Health Care / Medical Devices
- Index membership: S&P 500
- Next earnings date: not officially scheduled
This article is for informational purposes only and does not constitute investment advice, investment recommendation or an invitation to buy or sell securities. All information is based on sources believed to be reliable, but cannot be guaranteed. Readers should conduct their own research and, where appropriate, seek professional advice.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
